Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Bruker Announces New Microbiology Products and Workflows for Microbial Identification and Infection Control at ECCMID 2021

    Jul 14, 2021, 12:21 PM by
    Full story
  • QCI and IPQ Partner on Novel Approach to Drive More Effective Clinical Trials and Diagnostic Outcomes

    Jul 14, 2021, 12:21 PM by
    Quantum Computing Inc. (QCI) (OTCQB: QUBT), the leader in bridging the power of classical and quantum computing, has announced a partnership with IPQ Analytics, LLC (IPQ), a life sciences and healthcare analytics innovator that provides a new breed of solutions for improved diagnostics and clinical trial outcomes. Through the partnership, IPQ will analyze real world data to generate novel temporally-defined disease models by combining its unique top-down knowledge graph representation of the patient journey with QCI’s quantum-powered community detection technology.
    Full story
  • WCG Acquires Intrinsic Imaging, Leading Full-Service Medical Imaging Core Lab

    Jul 14, 2021, 12:21 PM by
    Acquisition Enriches WCG’s Scientific and Regulatory Capabilities with Comprehensive Services Ensuring Quality and Validity of Clinical Trial Results Across Drug, Medical Device and Artificial Intelligence Studie
    Full story
  • Idifarma launches accelerated pathway for complex drugs

    Jul 14, 2021, 12:21 PM by
    Full story
  • Friday Health Plans Partners With HealthSparq to Power New Digital Experience for Members

    Jul 14, 2021, 12:21 PM by
    Friday Health Plans implements HealthSparq's convenient and personalized provider search and price transparency tools for members.
    Full story
  • Scitara Corporation unleashes universal connectivity to redefine lab of the future

    Jul 14, 2021, 12:21 PM by
    Universal data connectivity for life science laboratories delivers seamless digital ecosystem and full automation of lab workflows – with the goal of accelerating scientific discovery
    Full story
  • AUI and Accumen Partner to Increase Crisis Resilience to Natural and Manmade Disasters for Healthcare Sector

    Jul 14, 2021, 12:21 PM by
    These new programs will ensure that healthcare organizations are better prepared to handle security threats, and power, water/waste management or supply chain disruptions.
    Full story
  • LabVantage Solutions Introduces Secure Web Portal with Version 8.7 of Its LabVantage LIMS Platform

    Jul 14, 2021, 12:21 PM by
    LabVantage 8.7 Introduces Secure Web Portal The latest version of LabVantage LIMS (laboratory information management system) includes a redesigned web portal that lets LabVantage customers extend appropriate access rights to their clients outside the laboratory. The new Portal protects customers’ valuable and sensitive data, while eliminating the need for manual requests for tests and other services. A new, next-generation user interface makes Portal features easier than ever to use for those outside the lab needing access to data but who are not familiar with LIMS. LabVantage 8.7 Highlights: • A secure customer self-service web Portal for external clients of the lab, ensuring faster and more complete client-submitted requests and direct access to more meaningful information and data. • Customers’ choice of “apps” that deliver various functions, such as Portal account management, request submissions, status tracking and test-results viewing, and requests for test kits. • Simple and intuitive user experience with clean, cockpit-style screens that allow users to navigate safely, efficiently, and with little or no training. • Lab administrator self-support leveraging existing LabVantage knowledge of functions, configuration tools, and other skills. • Available immediately.
    Full story
  • BOC Sciences Offers Pseudouridine and Its Derivatives to Promote mRNA Development

    Jul 14, 2021, 12:21 PM by
    Full story
  • Volpi partners with TOPIC Embedded Systems to offer intelligence-embedded optical measurement

    Jul 14, 2021, 12:21 PM by
    Volpi, a world leader in optoelectronics with operations in the U.S. and Switzerland, has partnered with Netherlands-based TOPIC Embedded Systems, a leader in embedded intelligence, to expand its portfolio of optoelectronic measurement solutions and further advance its digital initiatives.
    Full story
  • LIQUID STABLE, MATRIX PLUS™ CHEMISTRY REFERENCE MATERIALS NOW OFFERED BY VERICHEM LABORATORIES

    Jul 14, 2021, 12:21 PM by
    Verichem’s MATRIX PLUS™ Chemistry Reference Kit is expressly intended to support overall system QC and CLIA compliance within the clinical laboratory.
    Full story
  • Alfa Chemistry Diversifies Supply of Active Pharmaceutical Ingredients for Pharmaceutical Preparation

    Jul 14, 2021, 12:21 PM by
    Full story
  • Alfa Chemistry Materials Announces a New Product Offering of Quantum Dots

    Jul 14, 2021, 12:21 PM by
    Full story
  • Standigm Secures Strategic Investment from SK Chemicals for Expanding its AI-Drug Development Capacity

    Jul 14, 2021, 12:20 PM by
    Standigm Inc. (“Standigm”), a leading workflow artificial intelligence (AI) drug discovery company, and SK Chemicals Co., Ltd (“SK Chemicals”), a life science and green chemicals company, announced today that they have signed a strategic partnership contract for collaboration regarding clinical development of Standigm’s AI-driven drug candidate for non-alcoholic steatohepatitis (“NASH”) and the foundation of Standigm’s Synthesis Research Center within the headquarters of SK Chemicals. This partnership was made in conjunction with SK Chemicals’ participation in Standigm’s pre-IPO round of fundraising.
    Full story
  • Flywheel and HealthMyne Partner to Provide End-to-End Radiomic Data Management and Analysis

    Jul 14, 2021, 12:20 PM by
    Flywheel and HealthMyne: Combined technology solution to accelerate radiomics research and clinical trial outcomes
    Full story
  • Protheragen MedAI Fully Supports In Vitro Pharmacology Research for Drug Discovery

    Jul 14, 2021, 12:20 PM by
    Full story
  • FDS Amplicare Awards $25,000 Grant to CPESN Minnesota to Help 50 Community Pharmacies Expand Healthcare Services

    Jul 14, 2021, 12:20 PM by
    FDS Amplicare Awards $25,000 Grant to CPESN Minnesota to Help 50 Community Pharmacies Expand Healthcare Services
    Full story
  • New Cotiviti Research Captures Healthcare Payer Shift from Postpay to Prepay Claim Integrity

    Jul 14, 2021, 12:20 PM by
    Survey of >100 health plan leaders offers insight into the challenges of balancing prospective and retrospective approaches across enterprise payment integrity programs
    Full story
  • Strateos Makes Cloud Lab Software Available to In-House Labs

    Jul 13, 2021, 12:21 PM by User Not Found
    Bio-IT World | Strateos has launched its SmartLab Software which enables research organizations of any size to manage scientific workflows in-house while integrating automation with a modular, cloud-based software platform.
    Full story
  • Strep A Vaccine Development No Longer ‘A Bridge Too Far’

    Jul 8, 2021, 01:00 AM by User Not Found
    Bio-IT World | In at least two, placebo-controlled randomized trials getting underway in the next year, participants will be purposefully infected with a strain of group A streptococcus (Strep A) causing acute pharyngitis (strep throat) in a human challenge test of candidate vaccines intended to confer protection.
    Full story
  • «
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170 (current)
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy